Gene · 9739
Papers2,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blood T Helper Memory Cells: A Tool for Studying Skin Inflammation in HS? | Int J Mol Sci | 2023 | 37240200 | PubTator, text mining | PubMed |
| H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets. | Front Cell Dev Biol | 2023 | 37228649 | PubTator, text mining | PubMed |
| Epigenetic regulation of human-specific gene expression in the prefrontal cortex. | BMC Biol | 2023 | 37226244 | PubTator, text mining | PubMed |
| The function of histone methylation and acetylation regulators in GBM pathophysiology. | Front Oncol | 2023 | 37205197 | PubTator, text mining | PubMed |
| An acetylation-mediated chromatin switch governs H3K4 methylation read-write capability. | Elife | 2023 | 37204295 | PubTator, text mining | PubMed |
| Arabidopsis thaliana: a powerful model organism to explore histone modifications and their upstream regulations. | Epigenetics | 2023 | 37196184 | PubTator, text mining | PubMed |
| Screening and identification of key chromatin regulator biomarkers for ankylosing spondylitis and drug prediction: evidence from bioinformatics analysis. | BMC Musculoskelet Disord | 2023 | 37193965 | PubTator, text mining | PubMed |
| Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients. | Int J Mol Sci | 2023 | 37175579 | PubTator, text mining | PubMed |
| SET1 and p300 Act Synergistically, through Coupled Histone Modifications, in Transcriptional Activation by p53. | Cell | 2023 | 37172569 | PubTator, text mining | PubMed |
| Myosin in chromosome organisation and gene expression. | Biochem Soc Trans | 2023 | 37171068 | PubTator, text mining | PubMed |
| Epigenotype-genotype-phenotype correlations in SETD1A and SETD2 chromatin disorders. | Hum Mol Genet | 2023 | 37166351 | PubTator, text mining | PubMed |
| Identification and classification of papain-like cysteine proteinases. | J Biol Chem | 2023 | 37164157 | PubTator, text mining | PubMed |
| Combining globally search for a regular expression and print matching lines with bibliographic monitoring of genomic database improves diagnosis. | Front Genet | 2023 | 37152996 | PubTator, text mining | PubMed |
| Oncogenic signaling-mediated regulation of chromatin during tumorigenesis. | Cancer Metastasis Rev | 2023 | 37147457 | PubTator, text mining | PubMed |
| Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. | MedComm (2020) | 2023 | 37143582 | PubTator, text mining | PubMed |
| KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition. | Adv Sci (Weinh) | 2023 | 37142882 | PubTator, text mining | PubMed |
Pan-cancer analysis revealed H3K4me1 at bivalent promoters premarks DNA hypermethylation during tumor development and identified the regulatory role of DNA methylation in relation to histone modifications. | BMC Genomics | 2023 | 37138231 | PubTator, text mining | PubMed |
| Local genetic correlations exist among neurodegenerative and neuropsychiatric diseases. | NPJ Parkinsons Dis | 2023 | 37117178 | PubTator, text mining | PubMed |
| H3 Lysine 4 Methylation Is Required for Full Activation of Genes Involved in α-Ketoglutarate Availability in the Nucleus of Yeast Cells after Diauxic Shift. | Metabolites | 2023 | 37110165 | PubTator, text mining | PubMed |
| HMGXB4 Targets Sleeping Beauty Transposition to Germinal Stem Cells. | Int J Mol Sci | 2023 | 37108449 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9739/papers?page=14